Venn Therapeutics is an integrin therapeutics precision medicine company. We are developing a pipeline of novel, best-in-class agents that precisely target key mechanisms of cancer, fibrosis and NASH. Our mission is to contribute to a world without cancer. Our goal is to become the preeminent oncology franchise for pharmaceutical companies seeking the most promising advances in immuno-oncology, and to contribute to making that vision a reality.